OTCMKTS:PBIO
Pressure BioSciences, Inc Stock News
$0.239
-0.0009 (-0.375%)
At Close: May 17, 2024
Pressure BioSciences (OTCMKTS:PBIO) Stock Crosses Below 200 Day Moving Average of $2.48
08:08am, Wednesday, 17'th Nov 2021 Transcript Daily
Shares of Pressure BioSciences, Inc. (OTCMKTS:PBIO) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.48 and traded as low as $2.46. Pressure BioSciences shares last traded at $2.55, with a volume of 8,650 shares trading hands. The company has a market capitalization of $18.85 []
Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA / A
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA / A
Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or
Pressure Biosciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces
09:38am, Friday, 27'th Aug 2021
Image Provided By Pixabay Pressure Biosciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technology, has been aggressively pursuing strategic partnerships w
Pressure BioSciences Reports Strong 2nd Quarter Financial and Business Results; Looks Forward to an Even Stronger 2nd Half of 2021
01:23pm, Thursday, 26'th Aug 2021
Image Provided By Pixabay Pressure BioSciences, Inc (OTCQB:PBIO) has enjoyed a near record-breaking first half of 2021, reporting the second-highest revenue growth ever, driven by the company's aggres
Pressure BioSciences, Inc. Reports Strong Second Quarter 2021 Financial Results
09:45am, Thursday, 19'th Aug 2021
Significant Growth Reported in Total Revenue (127%), Instrument Sales (178%), and BaroFold/UST Services (298%); Significant Decrease in Operating Loss (51%) Achieved Investor Call Scheduled for Thursd
Pressure BioSciences to Host Q2 2021 Financial Results and Business Update on Thursday, August 19, 2021
10:05am, Wednesday, 18'th Aug 2021
Company to Discuss Strong Q2 2021 Financial Results, Give Update on Current Activities, and Take Questions on Aggressive Growth Plan Laid Out for the Company on August 5, 2021 SOUTH EASTON, MA / ACCES
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive PBI Agrochem Update, Followed by a Q&A Session, on Wednesday, August 18, 2021 SOUTH EASTON, MA / ACCESSWIRE / Aug
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
08:33am, Thursday, 12'th Aug 2021
PBI Agrochem Integration into the Sales Channels of Its Planned Asset Acquisition of a Global, Environmentally Responsible Agrochem Company is Expected to Result in a Significant Q3 2021 Impact
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
08:31am, Thursday, 12'th Aug 2021
PBI Agrochem Integration into the Sales Channels of Its Planned Asset Acquisition of a Global, Environmentally Responsible Agrochem Company is Expected to Result in a Significant Q3 2021 Impact SOUTH
Company's Strong First Half 2021 Viewed as Launch Pad for Accelerating Second Half and Growth Trajectory, Propelled by Multiple Platform Technologies Building Market Traction SOUTH EASTON, MA / ACCESS
Significant Order for Environmentally Friendly Agrochemical Material Placed to Fulfill Initial Demand; Subsidiary will House Announced Asset Acquisition from Global Agrochemicals Innovator SOUTH EASTO
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive UST Platform and Agrochem Asset Acquisition Update, Followed by a Q&A Session, on Wednesday, July 21, 2021 SOUTH
The leading developer of high-pressure-based platform technologies for life sciences applications worldwide, Pressure BioSciences (OTCQB: PBIO) (“PBI”) is slated to release its next major innovati